Please tell us which country and city you'd like to see the weather in.

Bristol-Myers Squibb

Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City.

Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."

BMS' primary R&D sites are located in Lawrence Township (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers), with other sites in Hopewell and New Brunswick, New Jersey, and in Braine-l'Alleud, Belgium, Tokyo, Japan and Bangalore, India.

History

Squibb was founded in 1858 by Edward Robinson Squibb in Brooklyn, New York. Squibb was known as a vigorous advocate of quality control and high purity standards within the fledgling pharmaceutical industry of his time, at one point self-publishing an alternative to the U.S. Pharmacopeia (Squibb's Ephemeris of Materia Medica) after failing to convince the American Medical Association to incorporate higher purity standards. Mentions of the Materia Medica, Squibb products, and Edward Squibb's opinion on the utility and best method of preparation for various medicants are found in many medical papers of the late 1800s. Squibb Corporation served as a major supplier of medical goods to the Union Army during the United States Civil War, providing portable medical kits containing morphine, surgical anesthetics, and quinine for the treatment of malaria (which was endemic in most of the eastern United States at that time).

Bristol (1866)

Bristol was a large sidewheel steamer launched in 1866 by William H. Webb of New York for the Merchants Steamship Company. One of Narragansett Bay's so-called "floating palaces", the luxuriously outfitted Bristol and her sister ship Providence, each of which could carry up to 1,200 passengers, were installed with the largest engines then built in the United States, and were considered to be amongst the finest American-built vessels of their era.

Both ships would spend their entire careers steaming between New York and various destinations in and around Narragansett Bay, Rhode Island. Bristol was eventually destroyed by a fire while in port in 1888.

Development

Bristol and Providence owed their existence to a short-lived company known as the Merchants Steamship Company, which placed the initial order for the vessels with the Webb shipyard in about 1865. Merchants Steamship was an amalgamation of three existing Narragansett Bay shipping lines, the Commercial Line, Neptune Line and Stonington Line. The Company intended to run the two steamers between New York and Bristol, Rhode Island in competition with the Fall River Line, which ran a similar service from New York to Fall River, Massachusetts (both Lines then linking up to railway lines that continued on to Boston).

Bristol, Pennsylvania

Bristol is a borough in Bucks County, Pennsylvania, 23 miles (37 km) northeast of Center City Philadelphia, opposite Burlington, New Jersey on the Delaware River. Bristol was first incorporated in 1720. Although its charter was revised in 1905, the original charter remains in effect, making Bristol one of the older boroughs in Pennsylvania. 7,104 people lived in Bristol in 1900; 9,256 in 1910; 10,273 in 1920; and 11,895 in 1940. The population was 9,726 at the 2010 census. The current Mayor is Patrick Sabatini Sr. The first female Mayor was Margaret Stakenas, elected in 1979.

History

Bristol was first settled in 1681 as Buckingham (for Buckingham, England). It was originally used as a port and dock. Bristol is rich in history, boasting many historic and restored houses that line the streets of Radcliffe and Mill.

Until 1725 Bristol served as county seat of Bucks County.

From its earliest days Bristol was a center of milling. With the building of the Delaware Canal and the Pennsylvania Railroad it became a center of transportation and an attractive location for industry.

Bristol (solitaire)

Bristol is a Patience game using a deck of 52 playing cards. It has an unusual feature of building regardless of suit on both the foundations and on the tableau; it is also one of the easiest to win.

Rules

Eight piles (or fans) of three cards each are dealt onto the tableau. Any king that is not on the bottom of its pile is placed underneath. Then three cards are placed under these piles. These form the bases for the three reserve piles.

Whenever an ace becomes available, it becomes a foundation, on which it can be built up regardless of suit up to a King. The same is done on the three other aces.

The top card of each pile on the tableau and the top card of each reserve pile is available to be built on the foundations and around the tableau. Like the foundations, the piles on the tableau are built down regardless of suit. Only one card can be moved at a time and when a pile becomes empty, it is never filled.

Cards in the stock are dealt onto the reserve three at a time, one for each pile. In effect, gaps on the reserve are filled during the deal; therefore, when a reserve pile becomes empty, it is not filled until the next batch of three cards is dealt.

Radio Stations - Bristol

RADIO STATION
GENRE
LOCATION
Retro Soul Radio London R&B UK
Energy FM DJ Mixes Non-Stop Dance UK
RadioFish Country,Oldies,60s UK
Radio Wivenhoe Varied UK
Scanner: VHF Marine Radio Public UK
RAT Radio Varied UK
Gem 106 Varied UK
BBC York Varied UK
Skyline Gold 60s,Soft Rock,Rock,Oldies,Easy,Country,Classic Rock,80s,70s UK
BBC Hindi - Tees Minute News Updates,Indian UK
BBC Radio 1 Pop UK
Free Radio Herefordshire & Worcestershire Pop,Top 40 UK
Miskin Radio Pop UK
EKR - WDJ Retro Rock,Adult Contemporary,Soft Rock UK
RollinRadio Electronica UK
Hard House UK Dance UK
My Social Radio Top 40 UK
Flight FM Electronica UK
Remarkable Radio Oldies UK
80s And More 80s UK
Sunshine Gold Oldies UK
House FM Dance,Electronica,Jungle UK
Jemm Two Indie Rock UK
Rickhits Pop UK
Dance Music 24/7 - EHM Productions 90s,Dance,Electronica UK
Hope FM 90.1 Christian Contemporary UK
Phoenix Radio Rock,Classic Rock UK
Gold FM Radio Rock,90s,80s,Adult Contemporary,Pop UK
87.7 Black Cat Radio Oldies,Pop UK
Radyo 90 Sports,Folk,Pop UK
Chester Talking Newspaper Flintshire Edition News UK
URN College UK
Sauce FM Dance UK
Anfield FM Sports UK
Sky News News UK
Citybeat 96.7FM Adult Contemporary UK
BBC Hindi - Din Bhar News Updates,Indian UK
RWSfm Varied UK
BBC Surrey Varied UK
106 Jack FM Oxfordshire Adult Contemporary UK
Bradley Stoke Radio Varied UK
Energy FM Old School Classics Dance UK
Deddington OnAir Rock,Pop UK
Summer Time Radio 90s,Dance,Electronica UK
Stomp Radio R&B UK
Stress Factor Dance,Electronica UK
Total Biker FM Rock,Punk UK
BBC Manchester Varied,News UK
BrooklynFM Rock,Classic Rock UK
FRED Film Ch9 Romanian Talk UK
Fantasy radio Varied UK

SEARCH FOR RADIOS

Podcasts:

developed with YouTube
PLAYLIST TIME:

Latest News for: bristol myers squibb

IHL elects new Board VP, approves new degree paths

The Enterprise-Tocsin 24 Jan 2025
The Board also approved a Miss ... One was to enter into an agreement with Bristol-Myers Squibb Company to purchase autologous cell therapy products that can alter T-cells and subsequently provide patients with an immunological response to cancer ... .

Eosinophilic Esophagitis Pipeline 2024: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights ...

GetNews 24 Jan 2025
Key companies developing therapies for Eosinophilic Esophagitis are - Bristol Myers Squibb, Ellodi Pharmaceuticals, AstraZeneca, Kyowa Hakko Kirin, Allakos, Pfizer, Revolo Biotherapeutics, EsoCap AG, NexEos Diagnostics, Inc., Celgene, and others ... 1 ... 2.

Lung Transplant Rejection Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight ...

GetNews 23 Jan 2025
Lung Transplant Rejection companies working in the treatment market are Corline Biomedical, MimeTech, TFF Pharmaceuticals, Kamada, Genentech, Bristol Myers Squibb, and others, are developing therapies for the Lung Transplant Rejection treatment.

You Were Diagnosed with Advanced Kidney Cancer. Now What?

The Call 23 Jan 2025
Indication ... Call 1-800-FDA-1088 ... Bristol-Myers Squibb at 1- 844-593-7869 as soon as you become aware of a pregnancy ... © 2025 Bristol-Myers Squibb Company. OPDIVO®, YERVOY® and the related logos are registered trademarks of Bristol-Myers Squibb Company.

Non Muscle Invasive Bladder Cancer Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress ...

GetNews 23 Jan 2025
Key companies developing therapies for Non Muscle Invasive Bladder Cancer are - Tollys, Vaxiion Therapeutics, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, Pfizer, Bristol-Myers ...

Interstitial Lung Disease Therapeutics Market Size in the 7MM is anticipated to increase by 2032 ...

GetNews 22 Jan 2025
... Boehringer Ingelheim, GlaxoSmithKline, Insmed Incorporated, United Therapeutics, Liquidia Technologies, Inc., Bristol-Myers Squibb, aTyr Pharma, Inc., AstraZeneca, and others ... Bristol Myers Squibb.

Beta Thalassemia Market on Track for Major Expansion by 2034, According to DelveInsight | Agios ...

GetNews 22 Jan 2025
... Pharma, Bristol-Myers Squibb, Hoffmann-La Roche, Sanofi, Novartis, EmeraMed, Pharmacosmos A/S, Celgene, DisperSol Technologies, LLC, Agios Pharmaceuticals, Shire, and others ... Bristol-Myers Squibb.

These NJ companies made Newsweek's list of most trustworthy in the U.S.

New Jersey Herald 22 Jan 2025
NJ 2025 State of the State. Phil Murphy on economy/innovation centers. New Jersey Gov. Phil Murphy gave his final State of the State address ... Food and beverage ... Princeton’s Bristol Myers Squibb ranked 28th, while Kenilworth-based Merck & Co ... Retail.

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva� in China as Second-line Treatment

Antara News 22 Jan 2025
References. 1. Sehn LH, Salles G ... 2 ... Carteyva�) is an autologous anti-CD19 CAR-T cell immunotherapy product independently developed by JW Therapeutics based on a CAR-T cell process platform of Juno Therapeutics (a Bristol Myers Squibb company) ... Source.

KRAS Inhibitors Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Novartis, ...

GetNews 22 Jan 2025
In February 2024, Bristol Myers Squibb reported that the US FDA has granted priority review status to the supplemental New Drug Application (sNDA) for KRAZATI in combination with cetuximab for the ...

Myelodysplastic Syndrome Therapeutics Market Size in the 7MM was ~USD 2,800 Million in 2023, is ...

GetNews 21 Jan 2025
In January 2025.- Bristol-Myers Squibb- The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to ... Bristol Myers Squibb.

Aravax Continues International Expansion with Appointment of Aled Williams as Chief Business Officer

Pharmiweb 21 Jan 2025
  ... Aled’s remit will include creating partnership opportunities for the Aravax portfolio as well as evolving the platform and asset strategy ... Prior to Shire, Aled held senior roles at Bristol Myers-Squibb, Novartis and Hoffman-La Roche.  ... .

Psoriasis Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | ...

GetNews 21 Jan 2025
“" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Psoriasis Market ... In December 2024, Bristol Myers Squibb (NYSE ... In March 2024, Alumis Inc ... Psoriasis Overview.

Most Viewed

×